0001225208-12-016000.txt : 20120706
0001225208-12-016000.hdr.sgml : 20120706
20120706121058
ACCESSION NUMBER: 0001225208-12-016000
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120701
FILED AS OF DATE: 20120706
DATE AS OF CHANGE: 20120706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Karen
CENTRAL INDEX KEY: 0001553599
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 12949952
MAIL ADDRESS:
STREET 1: 101 GORDON DRIVE
CITY: LIONVILLE
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 GORDON DR
STREET 2: P O BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 101 GORDON DRIVE
STREET 2: PO BOX 645
CITY: LIONVILLE
STATE: PA
ZIP: 19341-0645
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
3
1
doc3.xml
X0206
3
2012-07-01
0
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001553599
Flynn Karen
101 GORDON DRIVE
LIONVILLE
PA
19341
1
President, America's Region
Common Stock
3474.7818
D
Common Stock
155.8650
I
By Savings Plan
Stock Option (Right to Buy)
32.0900
2010-02-24
2019-02-24
Common Stock
2500.0000
D
Stock Option (Right to Buy)
40.8500
2012-02-22
2021-02-22
Common Stock
4281.0000
D
Stock Option (Right to Buy)
42.4400
2013-02-21
2022-02-21
Common Stock
4729.0000
D
Stock Option (Right to Buy)
42.6800
2011-03-22
2020-03-22
Common Stock
4729.0000
D
Stock Option (Right to Buy)
45.7800
2009-06-11
2018-06-11
Common Stock
2750.0000
D
limitedpowerflynn.txt
Joanne K. Boyle as Agent for Karen Flynn
2012-07-06
EX-24
2
limitedpowerflynn.txt
LIMITED POWER OF ATTORNEY FOR
WEST PHARMACEUTICAL SERVICES, INC.
SECTION 16(a) FILINGS
Know all by these presents that the undersigned hereby constitutes and appoints
each of John R. Gailey III, Joanne K. Boyle and Rachael M. Bushey, signing
singly, the undersigned's true and lawful attorney-in-fact to:
(1) Execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or shareholder of West Pharmaceutical Services, Inc.
(the "Company"), Forms 3, 4, and 5 and amendments thereto in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) Do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5
or amendment thereto and timely file such form with the United States Securities
and Exchange Commission (the "SEC") and any stock exchange or similar
authority; and
(3) Take any other action of any type whatsoever, which, in the opinion of such
attorney-in-fact, may be necessary or desirable in connection with the foregoing
authority, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms and conditions as such
attorney-in-fact may approve.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transaction in securities of the Company, unless
earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact. This Power of Attorney may be filed with the SEC
as a confirming statement of the authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 2nd day of July 2011.
_____________________________
/s/
Karen Flynn
Page 3 of 3
- 2 -
G:\stockmatters\limitedpowerflynn.doc